Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Citigroup Global Markets Australia Pty Limited and its associated entities have ceased to be substantial holders in Australian Clinical Labs Ltd as of 17 September 2024, reducing their voting power by a significant number of shares via securities lending agreements and ordinary stock market transactions. This marks a change in the shareholding structure of the company, potentially impacting investor relations and stock market performance.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.